中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
1期
35-36
,共2页
依达拉奉%疏血通%脑梗塞%老年人
依達拉奉%疏血通%腦梗塞%老年人
의체랍봉%소혈통%뇌경새%노년인
Edaravone%Shuxuetong%Brain infarction%Aged
目的 探讨依达拉奉联合疏血通治疗老年人急性脑梗死的临床疗效.方法 120例急性脑梗死患者按照治疗方法的不同分为观察组和对照组各60例,两组均采取常规治疗,对照组采用川穹嗪注射液治疗,观察组采用依达拉奉联合疏血通治疗,比较两组患者的临床疗效、日常生活活动能力(ADL)及神经缺损评分.结果 观察组基本痊愈25例,显著进步18例,进步12例,总有效率为91.7%;对照组总有效率为75.0%,两组差异有统计学意义(x2=6.86,P<0.05).观察组的ADL、神经功能缺损评分均显著优于对照组(均P<0.05).结论 在常规治疗的基础上采用依达拉奉联合疏血通治疗急性脑梗死的可显著促进患者神经功能恢复,值得临床推广.
目的 探討依達拉奉聯閤疏血通治療老年人急性腦梗死的臨床療效.方法 120例急性腦梗死患者按照治療方法的不同分為觀察組和對照組各60例,兩組均採取常規治療,對照組採用川穹嗪註射液治療,觀察組採用依達拉奉聯閤疏血通治療,比較兩組患者的臨床療效、日常生活活動能力(ADL)及神經缺損評分.結果 觀察組基本痊愈25例,顯著進步18例,進步12例,總有效率為91.7%;對照組總有效率為75.0%,兩組差異有統計學意義(x2=6.86,P<0.05).觀察組的ADL、神經功能缺損評分均顯著優于對照組(均P<0.05).結論 在常規治療的基礎上採用依達拉奉聯閤疏血通治療急性腦梗死的可顯著促進患者神經功能恢複,值得臨床推廣.
목적 탐토의체랍봉연합소혈통치료노년인급성뇌경사적림상료효.방법 120례급성뇌경사환자안조치료방법적불동분위관찰조화대조조각60례,량조균채취상규치료,대조조채용천궁진주사액치료,관찰조채용의체랍봉연합소혈통치료,비교량조환자적림상료효、일상생활활동능력(ADL)급신경결손평분.결과 관찰조기본전유25례,현저진보18례,진보12례,총유효솔위91.7%;대조조총유효솔위75.0%,량조차이유통계학의의(x2=6.86,P<0.05).관찰조적ADL、신경공능결손평분균현저우우대조조(균P<0.05).결론 재상규치료적기출상채용의체랍봉연합소혈통치료급성뇌경사적가현저촉진환자신경공능회복,치득림상추엄.
Objective To explore the clinical effect of edaravone combined with Shuxuetong in treatment of elderly patients with acute cerebral infarction.Methods 120 cases of acute cerebral infarction,according to the different treatment methods,were divided into two groups.The conventional treatment was given in two groups,the control group plus Chuanqiong hydrochloride injection,and the observation group adopted edaravone and Shuxuetong.The clinical efficacy,activities of daily living(ADL) and neurological deficit score were compared between two groups.Results There were 25 cases of basic recovery,18 cases of significant progress,progress in 12 cases in the observation group,total effective rate was 91.7% (55/60),the control group was 75.0% (45/60),the difference was statistically significant ( x2 =6.86,P < 0.05 ).Observation group had statistically significant difference than the control group between ADL and neurological deficit scores ( all P < 0.05 ).Conclusion On the basis of conventional therapy,the use of edaravone combined with Shuxuetong for acute ischemic stroke patients could significantly promote the recovery of neurological function and was worthy of promotion.